Clinical trial
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone
NCT05457855
Study timeline
Study start (actual)2022-02-01Date precision: day
Registry last updated2025-08-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Asthmaunresolved
Interventions
MontelukastDRUG · verified · RxNorm: montelukast
FluticasoneDRUG · verified · RxNorm: fluticasone
Sponsors & collaborators
Brigham and Women's Hospitallead sponsor
National Institute on Aging (NIA)collaborator
Rutgers Universitycollaborator
Johns Hopkins Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05457855 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.